Join Us
Join Us
Join Us
Back to top

Preserving Coverage + Treatment Options

We’re striving to protect what works and improve what doesn’t.

Join Us

The Problem

Canada is considering a national single-payer pharmacare system that could replace both public and private drug plans – disrupting coverage for the 27 million Canadians who already have private plans that work well.

The new system would include a policy called bulk purchasing, where the government negotiates lower prices based on a larger number of products being purchased. While this sounds efficient, it can delay access and exclude effective medicines based on cost alone, even those that people rely on daily to manage diabetes, contraception, and autoimmune disorders.

The Problem

Canada is considering a national single-payer pharmacare system that could replace both public and private drug plans – disrupting coverage for the 27 million Canadians who already have private plans that work well.

The new system would include a policy called bulk purchasing, where the government negotiates lower prices based on a larger number of products being purchased. While this sounds efficient, it can delay access and exclude effective medicines based on cost alone, even those that people rely on daily to manage diabetes, contraception, and autoimmune disorders.

The Impact

Limiting treatment options like this is a concern. A one-size-fits-all plan could mean:

Fewer drug choices

for doctors and patients.

Longer waits

for new medicines.

Coverage disruptions

to private health plans.

Prioritizing costs,

not patient care.

Fewer drug choices

for doctors and patients.

Longer waits

for new medicines.

Coverage disruptions

to private health plans.

Prioritizing costs,

not patient care.

The Solution

Canadians should be able to get the medicines they need, when they need them, regardless of age, income, or where they live. As Canada moves forward with its national pharmacare plan, we believe it’s crucial to expand coverage, not reduce options. 

We’re encouraging a flexible, hybrid model that: 

The Solution

Canadians should be able to get the medicines they need, when they need them, regardless of age, income, or where they live. As Canada moves forward with its national pharmacare plan, we believe it’s crucial to expand coverage, not reduce options. 

We’re encouraging a flexible, hybrid model that: 

1

Fills gaps for the uninsured and underinsured.

2

Preserves existing private plans for those who rely on them.

3

Ensures timely access to new medicines.

Join the Community

Sign up below to help us build a stronger, healthier future for every Canadian.

By signing up, you agree to receive periodic emails from Medicine Matters Canada containing news, updates, and ways to get involved. Medicine Matters Canada is an initiative of Innovative Medicines Canada (“IMC”). These emails may be sent on IMC’s behalf by our service provider. You can unsubscribe at any time. Contact: Innovative Medicines Canada | 310-99 rue Bank St. Ottawa, ON K1P 6B9 | info@imc-mnc.ca

Learn more about Preserving Coverage + Treatment Options

Let’s Fix What’s Broken, without Breaking What’s Working

Learn more

Patient Choice a Top Priority: Why Pharmacare Must Put Canadians First

Learn more

Canada’s National Pharmacare Plan – Boon or Bane?

Learn more